Outcome of Board Meeting

QMS Q4FY26 Investor Presentation

Intimation regarding the in-principle application submitted to NSE on Wednesday, March 25, 2026, for the migration of the Company’s equity shares from NSE Emerge to the NSE Main Board

Notice of Trading Window Closure in Accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015

Outcome of the Board Meeting held on March 25, 2026

Intimation to the Stock Exchange regarding compliance under Regulation 24(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations

Schedule of Analyst/Institutional Investor Meeting (Group Meeting) Dated March 02, 2026

Intimation of Schedule of Analyst -Institutional Investor Meeting

Investor Presentation

Intimation for Amendment of Term Sheet in Relation to Acquisition of Stake in Prometheus Healthcare